Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-07 Sale |
2024-05-09 4:10 pm |
Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Principal Accounting Officer |
236 | $7.76 | $1,831 | 11,571 (Direct) |
View |
| 2024-03-08 Sale |
2024-03-08 6:05 pm |
Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Vice President, Finance |
4,884 | $11.72 | $57,219 | 11,807 (Direct) |
View |
| 2024-03-04 Purchase |
2024-03-05 4:15 pm |
Fulcrum Therapeutics Inc. | FULC | Sapir Alex See Remarks |
43,360 | $11.35 | $492,028 | 43,360 (Direct) |
View |
| 2023-05-10 Sale |
2023-05-11 4:12 pm |
Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Principal Accounting Officer |
210 | $3.31 | $695 | 15,992 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-24 Option Award |
2025-01-28 4:15 pm |
N/A 2035-01-23 |
Fulcrum Therapeutics Inc. | FULC | Musso Alan A Chief Financial Officer |
285,000 | $0 | 285,000 (Direct) |
View |
| 2025-01-24 Option Award |
2025-01-28 4:15 pm |
N/A 2035-01-23 |
Fulcrum Therapeutics Inc. | FULC | Sapir Alex See Remarks |
582,000 | $0 | 582,000 (Direct) |
View |
| 2025-01-24 Option Award |
2025-01-28 4:15 pm |
N/A 2035-01-23 |
Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Principal Accounting Officer |
76,120 | $0 | 76,120 (Direct) |
View |
| 2025-01-24 Option Award |
2025-01-28 4:15 pm |
N/A 2035-01-24 |
Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer |
225,000 | $0 | 225,000 (Direct) |
View |
| 2024-11-12 Option Award |
2024-11-14 4:15 pm |
N/A 2034-11-11 |
Fulcrum Therapeutics Inc. | FULC | King Rachel K. Director |
60,000 | $0 | 60,000 (Direct) |
View |
Ownership |
2024-09-23 4:15 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
0 | $0 | 18,729,099 (Indirect) |
View |
| 2024-08-21 Other |
2024-08-23 4:10 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. 10% Owner |
8,500,000 | $0 | 20,109,704 (Indirect) |
View |
| 2024-07-03 Exercise |
2024-07-08 08:00 am |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Sapir Alex See Remarks |
150,000 | $3.27 | 2,473,760 (Direct) |
View |
| 2024-07-03 Exercise |
2024-07-08 08:00 am |
N/A 2033-05-11 |
Fulcrum Therapeutics Inc. | FULC | Sapir Alex See Remarks |
150,000 | $0 | 2,473,760 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-18 4:20 pm |
N/A 2034-06-16 |
Fulcrum Therapeutics Inc. | FULC | Ezekowitz Alan Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-18 4:20 pm |
N/A 2034-06-16 |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-18 4:20 pm |
N/A 2034-06-16 |
Fulcrum Therapeutics Inc. | FULC | Haviland Kate Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-18 4:20 pm |
N/A 2034-06-16 |
Fulcrum Therapeutics Inc. | FULC | GERAGHTY JAMES A Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-18 4:20 pm |
N/A 2034-06-16 |
Fulcrum Therapeutics Inc. | FULC | Dorton Katina Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-18 4:20 pm |
N/A 2034-06-16 |
Fulcrum Therapeutics Inc. | FULC | Collins James J. Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-18 4:20 pm |
N/A 2034-06-16 |
Fulcrum Therapeutics Inc. | FULC | Banks Sonja Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-06-17 Option Award |
2024-06-18 4:15 pm |
N/A 2034-06-16 |
Fulcrum Therapeutics Inc. | FULC | Hill Colin Director |
60,000 | $0 | 60,000 (Direct) |
View |
Ownership |
2024-06-18 4:10 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Hill Colin Director |
0 | $0 | 0 (Direct) |
View |
| 2024-03-18 Option Award |
2024-03-20 4:15 pm |
N/A 2034-03-17 |
Fulcrum Therapeutics Inc. | FULC | Horn Patrick Taylor Chief Medical Officer |
400,000 | $0 | 400,000 (Direct) |
View |
Ownership |
2024-03-20 4:10 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Horn Patrick Taylor Chief Medical Officer |
0 | $0 | 0 (Direct) |
View |
| 2024-01-26 Option Award |
2024-01-30 9:10 pm |
N/A 2034-01-25 |
Fulcrum Therapeutics Inc. | FULC | Tourangeau Greg Vice President, Finance |
93,820 | $0 | 93,820 (Direct) |
View |
| 2024-01-26 Option Award |
2024-01-30 9:05 pm |
N/A 2034-01-25 |
Fulcrum Therapeutics Inc. | FULC | Musso Alan A Chief Financial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2024-01-26 Option Award |
2024-01-30 9:00 pm |
N/A 2034-01-25 |
Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2024-01-17 Option Award |
2024-01-19 4:15 pm |
2024-02-07 2033-08-06 |
Fulcrum Therapeutics Inc. | FULC | Musso Alan A Chief Financial Officer |
61,822 | $0 | 61,822 (Direct) |
View |
| 2023-08-07 Option Award |
2023-08-09 4:16 pm |
N/A 2033-08-06 |
Fulcrum Therapeutics Inc. | FULC | Musso Alan A Chief Financial Officer |
432,800 | $0 | 432,800 (Direct) |
View |
Ownership |
2023-08-09 4:11 pm |
N/A N/A |
Fulcrum Therapeutics Inc. | FULC | Musso Alan A Chief Financial Officer |
0 | $0 | 0 (Direct) |
View |
Ownership |
2023-07-03 4:16 pm |
N/A 2033-05-11 |
Fulcrum Therapeutics Inc. | FULC | Sapir Alex See Remarks |
0 | $0 | 2,430,400 (Direct) |
View |
| 2023-06-27 Option Award |
2023-06-29 4:23 pm |
N/A 2033-06-26 |
Fulcrum Therapeutics Inc. | FULC | GERAGHTY JAMES A Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-27 Option Award |
2023-06-29 4:16 pm |
N/A 2033-06-26 |
Fulcrum Therapeutics Inc. | FULC | Haviland Kate Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-27 Option Award |
2023-06-29 4:16 pm |
N/A 2033-06-26 |
Fulcrum Therapeutics Inc. | FULC | Banks Sonja Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-27 Option Award |
2023-06-29 4:16 pm |
N/A 2033-06-26 |
Fulcrum Therapeutics Inc. | FULC | Dorton Katina Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-27 Option Award |
2023-06-29 4:16 pm |
N/A 2033-06-26 |
Fulcrum Therapeutics Inc. | FULC | Ezekowitz Alan Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-27 Option Award |
2023-06-29 4:16 pm |
N/A 2033-06-26 |
Fulcrum Therapeutics Inc. | FULC | Gould Robert J Interim President & CEO |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-27 Option Award |
2023-06-29 4:16 pm |
N/A 2033-06-26 |
Fulcrum Therapeutics Inc. | FULC | Collins James J. Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-04-26 Option Award |
2023-04-28 4:17 pm |
N/A 2033-04-25 |
Fulcrum Therapeutics Inc. | FULC | Hayes Melvin H. III Chief Operating Officer |
115,000 | $0 | 115,000 (Direct) |
View |
| 2023-04-26 Option Award |
2023-04-28 4:16 pm |
N/A 2033-04-25 |
Fulcrum Therapeutics Inc. | FULC | Oltmans Curtis Gale Chief Legal Officer |
127,500 | $0 | 127,500 (Direct) |
View |